Amends the current law in order that a health insurer would not require a physician, to participate in "capitation," or any other "alternative payment model" that creates a financial incentive for a physician to limit medically necessary care.
Summary
H5851 amends Rhode Island’s insurance laws governing contracts between health insurers and physicians. The bill would prohibit a health insurer from requiring a physician, as a condition of contracting, to participate in a financial or reimbursement incentive arrangement such as pay-for-performance, capitation, or another alternative payment model unless the program meets specified quality-based standards or is approved by the Office of the Health Insurance Commissioner. The stated purpose is to prevent payment structures that could pressure physicians to reduce medically necessary care or to avoid accepting higher-need patients.
In practical terms, the bill narrows the circumstances under which insurers may tie provider participation to incentive-based payment programs. It preserves the ability to use such models only when they align with recognized quality guidelines or receive regulatory approval, while blocking arrangements that create incentives to limit care or patient access. The act would take effect immediately upon passage.
Impact
The bill would amend Chapter 27-20.9 of the General Laws, specifically the section on contract terms with healthcare providers, by adding limits on insurer-imposed payment and reimbursement models. It would affect health insurers and physicians in Rhode Island by restricting mandatory participation in capitation and similar alternative payment models that may influence clinical decision-making or patient selection. The Office of the Health Insurance Commissioner would retain a role in approving acceptable programs, and insurers would need to ensure contracting practices comply with the new standards.
Sentiment
Based on the bill text and available context, the measure appears to be driven by concern for physician autonomy and patient access to medically necessary care. The bill’s sponsors are Democrats in the House, and there is no recorded committee transcript or vote history in the provided materials indicating organized opposition or support. Overall, the available context suggests a protective, consumer- and provider-focused policy approach rather than a controversial partisan issue.
Contention
The main point of contention is likely whether insurers should be allowed to require participation in capitation or other alternative payment models as a condition of contracting. Supporters would view the bill as preventing financial incentives that could encourage under-treatment or patient selection, while opponents may argue that it limits insurer flexibility to design cost-control and value-based payment arrangements. The bill also raises a regulatory question about how much discretion the Office of the Health Insurance Commissioner should have in approving acceptable incentive programs.